Anaplastic carcinoma of the thyroid gland: Treatment and outcome over 13 years at one institution

Journal of Surgical Oncology

Volumn 106, Issue 8, 2012, Pages 981-986

  Segerhammar, Ivan ^a   Larsson, Catharina ^a   Nilsson, Inga Lena ^a   Bäckdahl, Martin ^a   Höög, Anders ^a   Wallin, Göran ^b   Foukakis, Theodoros ^a   Zedenius, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

anaplastic thyroid carcinoma; prognostic factors; radiotherapy; survival

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CHEMORADIOTHERAPY; CLINICAL STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBTOTAL THYROIDECTOMY; SURVIVAL TIME; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROID NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84869498100     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23177     Document Type: Article

References (25)

1. Gilliland FD, Hunt WC, Morris DM, et al.: Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance. Epidemiology and End Results (SEER) program 1973-1991. Cancer 1997; 79: 564-573.
2. Dal Maso L, Lise M, Zambon P, et al.: Incidence of thyroid cancer in Italy, 1991-2005: Time trends and age-period-cohort effects. Ann Oncol 2011; 22: 957-963.
3. Are C, Shaha AR,: Anaplastic thyroid carcinoma: Biology, pathogenesis, prognostic factors, and treatment approaches. Surg Oncol 2006; 13: 453-464.
4. Kebebew E, Greenspan FS, Clark OH, et al.: Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 2005; 103: 1330-1335.
5. Giuffrida D, Gharib H,: Anaplastic thyroid carcinoma: Current diagnosis and treatment. Ann Oncol 2000; 11: 1083-1089.
6. Yu GP, Li JC, Branovan D, et al.: Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid 2010; 20: 465-473.
7. Bhatia A, Rao A, Ang KK, et al.: Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy. Head Neck 2010; 32: 829-836.
8. Nilsson O, Lindeberg J, Zedenius J, et al.: Anaplastic giant cell carcinoma of the thyroid gland: Treatment and survival over a 25-year period. World J Surg 1998; 22: 725-730.
9. Wiseman SM, Loree TR, Rigual NR,: Anaplastic transformation of thyroid cancer: Review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 2003; 25: 662-670.
10. Junor EJ, Paul J, Reed NS,: Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 1992; 18: 83-88.
11. Passler C, Scheuba C, Prager G, et al.: Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbecks Arch Surg 1999; 384: 284-293.
12. Albores-Saavedra J, Henson DE, Glazer E, et al.: Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype-papillary, follicular, and anaplastic: A morphological and epidemiological study. Endocr Pathol 2007; 18: 1-7.
13. Hundahl SA, Cady B, Cunningham MP, et al.: Initial results from at prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation Study. Cancer 2000; 89: 202-217.
14. O'Neill JP, Power D, Condron C, et al.: Anaplastic thyroid cancer, tumorigenesis and therapy. Ir J Med Sci 2010; 179: 9-15.
15. Tennvall J, Lundell G, Wahlberg P, et al.: Anaplastic thyroid carcinoma: Three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 2002; 86: 1848-1853.
16. Ordonez N, Baloch Z, Matias-Gulu X, et al.: Undifferentiated (anaplastic) carcinoma. In:, DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors: World Health Organization classification of tumors. Pathology and genetics of tumors of endocrine organs. Lyon: IARC Press; 2004. pp. 77-80.
17. Jereb B, Stjernswärd J, Löwhagen T,: Anaplastic giant-cell carcinoma of the thyroid: A study of treatment and prognosis. Cancer 1975; 35: 1293-1295.
18. Smallridge RC, Copland JA,: Anaplastic thyroid carcinoma: Pathogenesis and emerging therapies. Clin Oncol 2010; 22: 486-497.
19. Wallin G, Bäckdahl M, Tallroth-Ekman E, et al.: Co-existent anaplastic and well differentiated thyroid carcinomas: A nuclear DNA study. Eur J Surg Oncol 1989; 15: 43-48.
20. Harach HR, Franssila KO, Wasenius VM,: Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer 1985; 56: 531-538.
21. Furmanchuk AW, Roussak N, Ruchti C,: Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy study of 215 patients. Histopathology 1993; 23: 319-325.
22. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, et al.: Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 1993; 71: 4022-4029.
23. Roche B, Larroumets G, Dejax C, et al.: Epidemiology, clinical presentation, treatment and prognosis of a regional series of 26 anaplastic thyroid carcinomas (ATC). Comparison with the literature. Endocrinol (Paris) 2010; 71: 38-45.
24. Kim TY, Kim KW, Jung TS, et al.: Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head Neck 2007; 29: 765-772.
25. Lundgren CI, Hall P, Dickman PW, et al.: Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer. Br J Surgery 2007; 94: 571-577.